Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001127602-17-011763

Options or other derivatives

  • Chief Medical Officer acquired 110,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Faleck Herbert J Chief Medical Officer 2017-03-13 Grant or award · Stock Option (right To Purchase) +110,000 $8.86 $974,600 110,000 D: show line 1 in the form
Loading xslF345X03/form4.xml…